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Each heartbeat is followed by a refractory period. Recovery from refractoriness is known as Ca2+ release restitution (CRR),
and its alterations are potential triggers of Ca2+ arrhythmias. Although the control of CRR has been associated with SR Ca2+ load
and RYR2 Ca2+ sensitivity, the relative role of some of the determinants of CRR remains largely undefined. An intriguing
point, difficult to dissect and previously neglected, is the possible independent effect of SR Ca2+ content versus the velocity of
SR Ca2+ refilling on CRR. To assess these interrogations, we used isolated myocytes with phospholamban (PLN) ablation
(PLNKO), knock-in mice with pseudoconstitutive CaMKII phosphorylation of RYR2 S2814 (S2814D), S2814D crossed with
PLNKO mice (SDKO), and a previously validated human cardiac myocyte model. Restitution of cytosolic Ca2+ (Fura-2 AM) and
L-type calcium current (ICaL; patch-clamp) was evaluated with a two-pulse (S1/S2) protocol. CRR and ICaL restitution increased
as a function of the (S2-S1) coupling interval, following an exponential curve. When SR Ca2+ load was increased by increasing
extracellular [Ca2+] from 2.0 to 4.0 mM, CRR and ICaL restitution were enhanced, suggesting that ICaL restitution may
contribute to the faster CRR observed at 4.0 mM [Ca2+]. In contrast, ICaL restitution did not differ among the different mouse
models. For a given SR Ca2+ load, CRR was accelerated in S2814Dmyocytes versus WT, but not in PLNKO and SDKOmyocytes
versus WT and S2814D, respectively. The model mimics all experimental data. Moreover, when the PLN ablation-induced
decrease in RYR2 expression was corrected, the model revealed that CRR was accelerated in PLNKO and SDKO versus WT and
S2814D myocytes, consistent with the enhanced velocity of refilling, SR [Ca2+] recovery, and CRR. We speculate that refilling
rate might enhance CRR independently of SR Ca2+ load.
Introduction
With each heartbeat, Ca2+ enters the cell through voltage-gated
L-type Ca2+ channels to trigger Ca2+ release from the SR via CICR
(Fabiato and Fabiato, 1977). Ca2+ released from the SR activates
the myofilaments that drive contraction. Relaxation occurs
when SR Ca2+ release is terminated, allowing the effective re-
sequestration of cytosolic Ca2+ into the SR by SERCA2a and its
extrusion from the cell by the Na+/Ca2+ exchanger. This results
in a decrease in cytosolic Ca2+. After SR Ca2+ release, time must
elapse before a second release event of equal amplitude can
take place; that is, recovery of SR Ca2+ release must occur
(DelPrincipe et al., 1999). This recovery from refractoriness is
usually known as Ca2+ release restitution (CRR), which is a
fundamental cellular property in determining beat-to-beat stability
of CICR and hence is primarily involved in cardiac function and
dysfunction. For instance, Ca2+ alternans, a gold standard ex-
ample of beat-to-beat instability in cardiac myocytes, appears
tightly associated with alterations in CRR (Hüser et al., 2000;
Kornyeyev et al., 2012; Shkryl et al., 2012; Zhong et al., 2016;
Sun et al., 2018). Moreover, CRR is significantly accelerated in
postinfarction myocytes, thereby accounting for increased
vulnerability of these myocytes to diastolic spontaneous ar-
rhythmogenic Ca2+ waves and arrhythmias (Terentyev et al.,
2002, 2003; Szentesi et al., 2004).
At the cellular level, several factors appear to affect refrac-
toriness of SR Ca2+ release, including L-type Ca2+ current (ICaL),
ryanodine receptors (RYR2) refractoriness and the mechanisms
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involved in the regulation of SR Ca2+ load (Szentesi et al., 2004;
Sobie et al., 2005; Ramay et al., 2011). However, and despite its
physiological and clinical importance, the mechanisms un-
derlying functional inactivation of Ca2+ release and the rela-
tive significance of CRR determinants remain not completely
clear. Terentyev et al. (2008) concluded that calsequestrin
plays a key role in CRR because it determines the “functional
size and stability” of SR Ca2+ store. Other authors have shown
that interventions which accelerate or slow SR refilling ac-
celerate or slow CRR, respectively, independently of changes
in cytosolic Ca2+ (Szentesi et al., 2004). Extending these previous
findings, it has been shown that CRR depends not only on SR
Ca2+ refilling but also on changes in RYR2 function itself, in-
cluding the variations in Ca2+ sensitivity produced by muta-
tions or post-translational modifications of the channel (Ramay
et al., 2011; Zhong et al., 2016; Sun et al., 2018). Indeed, RYR2
refractoriness appears as a main factor in the determination of
CRR and Ca2+ alternans (Picht et al., 2006; Belevych et al., 2012;
Wang et al., 2014).
In previous studies, the relative role played by the velocity of
SR Ca2+ refilling versus the level of SR Ca2+ load on CRR was not
yet defined. Because the acceleration of SR Ca2+ refilling in-
creases SR Ca2+ content, this intriguing aspect is difficult to
dissect experimentally. However, the relative importance of
these two factors on CRR might provide a clue to further
clarify its underlying control mechanisms. If SR Ca2+ load,
acting either directly on RYR2 (Jiang et al., 2007; Peng et al.,
2016) or indirectly through the regulation of accessory luminal
regulatory proteins (Pritchard and Kranias, 2009; Faggioni and
Knollmann, 2012; Marty, 2015), contributes to the recovery of
RYR2 from refractoriness, then the velocity of SR Ca2+ re-
filling might be of relevance. In contrast, if the recovery of
Ca2+ release from refractoriness lags behind the recovery of
SR Ca2+ load, as was demonstrated by Belevych et al. (2012),
the velocity of SR Ca2+ refilling might not be a critical de-
terminant of CRR.
In the present work, we combined experiments in genetically
modified mice with mathematical modeling to examine the time
course of CRR and dissect the different mechanisms involved
in this recovery (i.e., RYR2 Ca2+ sensitivity, SR Ca2+ load, and
the velocity of SR Ca2+ reuptake). We used mice with (1)
phospholamban (PLN) ablation (PLNKO) to increase the ve-
locity of SR Ca2+ reuptake and SR Ca2+ load, (2) knock-in mice
with pseudoconstitutive phosphorylation of the Ser2814 Ca2+/
calmodulin-dependent protein kinase II (CaMKII) site on
RYR2 (S2814D) exhibiting increased RYR2 Ca2+ sensitivity
(Wehrens et al., 2004; van Oort et al., 2010), and (3) a cross
of the PLNKO and S2814D mice (PLNKO×S2814D [SDKO];
Mazzocchi et al., 2016; Valverde et al., 2019) to produce ac-
celeration of SR Ca2+ reuptake and increased RYR2 activity.
The experimental conditions of the different models were reca-
pitulated in a mathematical human myocyte model (Mazzocchi
et al., 2016). The results indicated that SR Ca2+ load and RYR2
Ca2+ sensitivity are major determinants of CRR. Moreover,
mathematical modeling led us to suggest that the velocity of SR




Experiments were performed in 3–4-mo-old male mutant
PLNKO mice (Luo et al., 1994), RYR2-S2814D+/+ knock-in mice
(S2814D; van Oort et al., 2010), and SDKOmice (Mazzocchi et al.,
2016; Valverde et al., 2019). C57BL/6 mice, the genetic back-
ground of the different strains, were used as control animals
(WT mice). Murine genotype was confirmed by PCR analysis
using mouse tail DNA and specific primers for each mutation
(Mazzocchi et al., 2016; Valverde et al., 2019). Animals were
anesthetized with an intraperitoneal injection of ketamine–
diazepam (100 mg/kg and 5 mg/kg, respectively). Central tho-
racotomy and heart excision were performed immediately after
phase III anesthesia was reached, verified by the loss of pedal
withdrawal reflex. All experiments involving mice were per-
formed as per institutional guidelines and appropriate laws and
were approved by the Faculty ofMedicine, University of La Plata
Institutional Animal Care and Use Committee (CICUAL no. T05-
01-17).
Myocyte isolation
We used ventricular myocytes isolated from male mice in ac-
cordance with a modified protocol of Petroff et al. (2000).
Briefly, the hearts were excised, cannulated in situ, and retro-
gradely perfused on a Langendorff system. Hearts were perfused
at 37°C for 4 min with Tyrode solution containing EGTA (0.1
mM) and then immediately perfused for 7–9 min with a Ca2+-
free solution comprising (in mM): 140 NaCl, 4.69 KCl, 1.05
MgSO4, 10 HEPES, 0.35 NaH2PO4, 11.1 glucose, and collagenase
type 2 (0.5 mg/ml; Worthington Biochemical), pH 7.4. When
hearts became flaccid (15–20 min), they were off-hook down,
and myocytes were manually dissociated. After isolation, ven-
tricular myocytes were slowly recalcified and kept at room
temperature in a solution containing 1 mM Ca2+ until used.
Intracellular Ca2+ measurements
Isolated myocytes were loaded at room temperature with 5 µM
Fura-2 acetoxymethyl ester (a cell-permeant form of Fura-2;
Thermo Fischer Scientific) in Tyrode solution (HEPES buff-
ered) containing 1 mMCa2+ for 15 min. After being washed twice
with 2 mM Ca2+ Tyrode solution, the cells were left for de-
esterification for 30 min. Only rod-shaped myocytes with clear
and distinct striations were used. Experiments were performed
at room temperature (22–24°C) in Tyrode solution. The com-
position of the experimental Tyrode solution was as described
above in the presence of 2 mM Ca2+ unless otherwise specified
(pH 7.4; equilibrated with 100% O2). The myocytes were field
stimulated, and contractility and Fura-2 fluorescence were
monitored with an IonOptix setup configured with 360- and
380-nm excitation filters, a 400-nm dichroic mirror, and a 510 ±
40-nm emission filter. A fluorescence ratio (360 nm/380 nm)
was used to assess diastolic and systolic Ca2+ and amplitude of
the Ca2+ transient (Petroff et al., 2000).
Ca2+ restitution protocols
Restitution of Ca2+ transients was explored by applying an extra
stimulation pulse (S2) with respect to the regular pacing pulses
Cely-Ortiz et al. Journal of General Physiology 2 of 13
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(S1) at different time intervals (S2-S1 coupling intervals), as
shown in Fig. 1 A. At each time interval, cytosolic Ca2+ transient
recovery was calculated as the percentage S2 (A2) and S1 (A1)
ratio amplitudes, using the following equation:
CRR (%)  A2
A1
× 100.
CRR (%) was plotted as a function of the (S2-S1) coupling interval
(Fig. 1 B) to obtain CRR curves. CRR curves were well fitted by a
single exponential function, and the time constant of the expo-
nential growth (τ) was obtained.
SR Ca2+ content was assessed by rapid application of a 10 mM
caffeine pulse. Pulses were applied in the absence of field elec-
trical stimulation.
Measurements of Ca2+ currents
The ICaL was recorded with whole-cell configuration of the
patch-clamp technique using voltage-clamp configuration. An
Axopatch 200B amplifier (Molecular Devices) and a Digidata
1200 analog-to-digital converter (Axon Instruments) were used
to acquire ICaL with pClamp 6 software (Molecular Devices).
The voltage protocol was performed with a sampling rate of 5
kHz and a low pass filter of 2 kHz. To record the I-V relationship,
currents were evoked from a holding potential of −80 mV to a
200-ms prepulse of −40 mV and subsequently to 500-ms test
pulses ranging from −40 mV to +35 mV, in 5-mV increments,
with a stimulus frequency of 0.1 Hz. Nifedipine (50 µM) com-
pletely blocked the currents evoked by the I-V and restitution
protocols (data not shown). The restitution protocol was per-
formed recording the currents evoked from a holding potential
of −50 mV (used to inactivate sodium channels) to a 50-ms test
pulse of 0 mV (S1), back to −50 mV, and test pulsed again to
0 mV, with increasing time intervals of 50 ms (S2). A restitution
protocol from a holding potential of −60mVwas also assessed in
some experiments. Borosilicate patch pipettes were pulled with
a P-97 puller (Sutter Instruments) to a final resistance of 2.5MΩ.
The pipette was filledwith (inmM): 135 CsCl, 1 MgCl2, 4 Na2ATP,
1 EGTA, 10HEPES, pH 7.4, with CsOH (final concentration of Cs+,
140 mM). The external solution contained (in mM): 5 CsCl, 120
NaCl, 1 MgCl2, 10 HEPES, 10 triethylammonium chloride, 5 4-
aminopyridine, 2 or 4 CaCl2, 5 glucose, pH 7.2, with HCl. The
patch-clamp data were processed with ClampFit 10.3 (Molecular
Devices) and analyzed using Prism 6 software (GraphPad Soft-
ware). All experiments were performed at room temperature
(22–24°C).
Modeling
A previously employed human myocyte model, the Negroni-
Lascano model, based on a modified ten Tusscher–Panfilov
structure (ten Tusscher et al., 2004), was used (Mazzocchi
et al., 2016). A detailed description of the model is provided
in Fig. S1 and the supplemental text (see bottom of PDF).
To simulate the behavior of S2814D and PLN ablated my-
ocytes, an increase in RYR2 Ca2+ release or in SERCA2a Ca2+
uptake, respectively, was added as appropriate (S2814Dsim,
PLNKOsim). These changes were represented as an increase in
Ca2+ sensitivity of RYR2 (Shannon et al., 2005) to obtain an
increase in the open probability (conductance) of RYR2 similar
to that described experimentally by van Oort et al. (2010),
working in S2814D myocytes, and as a decrease in SERCA2a Kd,
to obtain an increase in SERCA2a activity similar to that de-
scribed in PLNKO (Luo et al., 1994), respectively. Moreover, to
compare the model with the experimental data, PLNKOsim my-
ocytes were complemented with a 33% decrease in RYR2 con-
ductance to reproduce the reported compensatory decrease in
RYR2 expression of PLNKO mouse myocytes (Chu et al., 1998;
Mazzocchi et al., 2016). These simulated conditions allowed us to
study the effect of RYR2 activity and SR Ca2+ reuptake on CRR as
a function of SR Ca2+. SDKOsim was simulated as the combination
of the S2814Dsim and PLNKOsim alterations. We have already
shown that the model mimicked the behavior of mouse my-
ocytes in the different strains (Mazzocchi et al., 2016).
After 100 beats of stabilization at a frequency of 70 stimuli/
min, an extra stimulus was applied at different, increasingly
shorter times from the onset of the last stabilized stimulated
beat (beat number 100). Restitution of SR Ca2+ release through
RYR2 (Irel) in micromoles of Ca2+ per millisecond, Ca2+ transient
(CRR) in micromoles of [Ca2+]i, and ICaL in picoamperes were
Figure 1. Experimental protocol. (A) Experimental protocol used to assess
cytosolic Ca2+ release refractoriness in mouse myocytes using electrical field
stimulation. Vertical red dashes below the typical records (S1 and S2) denote
basal stimulation frequency (1 Hz) and the extra stimulus, respectively. After
a brief conditioning period at 1 Hz, the extra stimulus S2 was applied at
successively shorter S2-S1 coupling intervals. Bottom: A typical experimental
curve. A1, amplitude of the Ca2+ transient during regular pacing; A2, amplitude
of the Ca2+ transient after the extra systolic stimulation. CRR was calculated
as the percentage ratio between A2 and A1. (B) CRR plotted as a function of
S2-S1 interval. Points could be well fitted by an exponential function. The time
constant of this function (τ) was used to estimate the rate of CRR.
Cely-Ortiz et al. Journal of General Physiology 3 of 13
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measured in the human myocyte model that mimics WT,
S2814D, PLNKO, and SDKO mouse conditions at external Ca2+
concentrations yielding stabilized beats free from arrhythmias
(1.5–2.5 mM). Ca2+ restitution curves were fitted to an expo-
nential function, and the exponential time constant, τ, was
plotted as a function of SR Ca2+ load at each extracellular Ca2+
concentration. Of note, in the mathematical model, it is possible
to evaluate either the restitution of Ca2+ transients (CRR) or to
directly compute the restitution of Irel, thus avoiding post-
release mechanisms that can influence the shape of the Ca2+
transient. As shown in Fig. S2, Ca2+ transients or Irel restitution
curves have similar behavior in the human myocyte model.
Therefore, we used Irel to estimate CRR in the mathematical
model, unless otherwise stated.
Statistics
Continuous variables were expressed as mean ± SEM. When
several cells per animal were used, results of the number of cells
in each animal were averaged. The number used for statistical
analysis corresponds to the number of animals. Results were
compared with either unpaired Student’s t test or one-way
ANOVA followed by Tukey’s post hoc test, as appropriate. P <
0.05 was considered significant. Graph Pad Prism 6.0 software
package was used for statistical analyses.
Online supplemental material
Fig. S1 shows a schematic diagram of the model. Fig. S2 dem-
onstrates that Ca2+ transients or Irel restitution curves have a
similar behavior in the human myocyte model. Fig. S3 shows
that pseudophosphorylation of RYR2 at the Ser2814 site
(S2814D) significantly increases maximal density of high-affinity
[3H]ryanodine binding sites and the frequency of SR Ca2+ sparks.
Fig. S4 displays raw data of the experimental protocol used to
determine CRR curves. Fig. S5 depicts raw data and overall re-
sults of ICaL restitution in WT, PLNKO, and S2814D myocytes,
recorded at 0 mV from a holding potential of −60 mV. Fig. S6
shows that the increase in extracellular Ca2+ and the ablation of
PLN enhance ICaL inactivation kinetics. Fig. S7 shows Western
blots and overall results of the decreased expression of RYR2 in
PLNKO and SDKO mouse hearts and indicates that Casq2 ex-
pression does not significantly change in S2814D, PLNKO, and
SDKO with respect to WT mouse hearts.
Results
Restitution of SR Ca2+ release is enhanced by increasing SR
Ca2+ load
To explore the effects of increasing SR Ca2+ content on CRR, we
created CRR curves in myocytes from WT mice at two different
extracellular Ca2+ concentrations. SR Ca2+ content was estimated
by caffeine pulses at the same extracellular Ca2+ concentrations.
Fig. 2 shows that an increase in extracellular Ca2+ increases SR
Ca2+ content both experimentally (Fig. 2 A) and in model sim-
ulations (Fig. 2 B). Fig. 2 C depicts typical experimental CRR
curves obtained inWTmyocytes at 2.0 and 4.0mM extracellular
Ca2+, showing that τ decreases with increasing SR Ca2+ load
(Fig. 2 C, inset). Fig. 2 D shows that similar results were obtained
for Irel in the human myocyte model; that is, the increase in SR
Ca2+ enhanced Irel restitution (Fig. 2 D, inset). Of note, in-
creasing extracellular Ca2+ from 2.0 to 4.0 mM did not affect
diastolic [Ca2+]i significantly (2.0 mM, 1.25 ± 0.03 F/F0; 4.0 mM,
1.31 ± 0.06 F/F0; n = 8). Taken together, these results indicate
that the increase in SR Ca2+ load by increasing extracellular Ca2+
enhances CRR, as evidenced by the decrease in τ.
CRR was accelerated by PLN ablation and constitutive
pseudophosphorylation of RYR2 by CaMKII
It is well known that PLN ablation increases SR Ca2+ load by
increasing the speed of Ca2+ sequestration (Luo et al., 1994).
Moreover, it has also been described that pseudophosphor-
ylation of RYR2 at the Ser2814 site increases the activity of RYR2
(Wehrens et al., 2004; Voigt et al., 2012; Mazzocchi et al., 2016;
Valverde et al., 2019). This contention is further supported by
the results obtained from [3H]ryanodine binding studies in
ventricular homogenates and from SR Ca2+ sparks in isolated
myocytes using confocal microscopy (Fig. S3). Pseudophos-
phorylation of RYR2 at the Ser2814 site (S2814D) significantly
increases the maximal density of high-affinity [3H]ryanodine
binding sites (Fig. S3 A). In addition, the frequency of SR Ca2+
sparks is higher in S2814D than in WT myocytes at 6.0 mM
extracellular Ca2+ (Fig. S3 B). Normalization of these data by the
SR Ca2+ content further increases the difference in spark fre-
quency (Fig. S3 B). Confirming previous findings (Wehrens
et al., 2004; van Oort et al., 2010; Mazzocchi et al., 2016;
Valverde et al., 2019), these results indicate that CaMKII-
dependent phosphorylation of RYR2 enhances the activity of
the channels.
Previous experiments have shown that increasing SR Ca2+
refilling (PLNKO) accelerates CRR (Szentesi et al., 2004).
Moreover, increasing RYR2 activity decreases its refractoriness
(Wang et al., 2014; Sun et al., 2018) and enhances CRR (Sun et al.,
2018). We evaluated the hypothesis that CRR is accelerated by
the increased activity of RYR2 produced by pseudophosphor-
ylation of RYR2 at the S2814 site in S2814D mice and is further
enhanced when both alterations (i.e., increasing SR Ca2+ refilling
and RYR2 activity) are present, like in SDKO myocytes. Fig. 3 A
shows typical raw data of the experimental protocol used. Fig. S4
shows, in more detail, the experimental protocol for all four
strains. Fig. 3 B shows CRR curves obtained in WT, S2814D,
PLNKO, and SDKO myocytes at the same extracellular Ca2+
concentration (2.0 mM). Fig. 3 C shows similar behavior in the
human myocyte model mimicking the different genetically al-
tered mice. Fig. 3 D shows overall experimental results of τ
values of CRR of the four mouse models, which were reproduced
by the human myocyte model in Fig. 3 E. As expected, τ was
significantly decreased in PLNKO and SDKO myocytes relative
toWTmyocytes. In contrast, τ values were similar (only slightly
lower) in S2814D versus WT myocytes and did not decrease in
SDKO versus PLNKO myocytes, despite the enhanced activity of
RYR2 in S2814D and SDKO.
A possible explanation in interpreting these somewhat un-
expected results can stand on the fact that CRR also depends on
the electrical activity of cardiomyocytes (i.e., the action potential
[AP] recovery) and, more important, the associated ICaL, which
Cely-Ortiz et al. Journal of General Physiology 4 of 13
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determines CICR (Fabiato and Fabiato, 1977). Previous experi-
ments performed in the intact heart showed that the AP resti-
tution did not differ between S2814D and SDKO hearts
(Mazzocchi et al., 2016). In preliminary experiments, we further
observed that AP restitution in PLNKO and WT was also similar
to that previously described in SDKO and S2814D hearts. These
results would indicate that AP restitution was not responsible for
the CRR differences observed among the different strains.
However, all these experiments were performed in the intact
heart and at a different temperature and may not reflect the
restitution of ICaL. We therefore performed voltage-clamp ex-
periments in isolated myocytes to examine possible changes
produced by PLN ablation and RYR2 pseudophosphorylation on
ICaL as the trigger for Ca2+ release. The effect of increasing ex-
tracellular Ca2+ was also examined. Fig. 4 A shows that I-V re-
lationships were similar in WT, PLNKO, and S2814D myocytes.
As expected, ICaL increased when extracellular Ca2+ was in-
creased from 2.0 to 4.0 mM Ca2+. Fig. 4 B depicts original traces
of the protocol used to assess ICaL restitution kinetics in the
different strains and in WT myocytes at 2.0 and 4.0 mM Ca2+,
and Fig. 4, C and E, shows experimental ICaL restitution curves.
Increasing extracellular Ca2+ from 2.0 to 4.0 mM enhanced ICaL
inactivation recovery (Fig. 4 C). Similar results were obtained in
the mathematical model when extracellular Ca2+ was increased
(Fig. 4 D). These findings indicate that the faster recovery of ICaL
at 4.0 mMCa2+ may influence the faster recovery of CRR and Irel
at the higher extracellular Ca2+ concentrations. In contrast, PLN
ablation or Ser2814 pseudophosphorylation did not significantly
alter ICaL restitution (Fig. 4 E). The mathematical model repro-
duced the experimental data (Fig. 4 F). Similar results were
obtained when a holding potential closer to resting membrane
potential was employed (−60 mV) and consequently ICaL resti-
tution was accelerated. As shown in Fig. S5, the recovery from
inactivation of ICaL (measured in this case as the nifedipine-
sensitive current) was still similar among the different mouse
strains studied, further supporting the contention that ICaL
restitution cannot account for the enhanced CRR produced by
PLN ablation or CaMKII-dependent activation of RYR2. A pos-
sible limitation of these ICaL measurements is that the myocytes
were dialyzed with EGTA, which may prevent the physiological
Ca2+-dependent ICaL inactivation, impacting the extent of re-
covery from inactivation. The EGTA concentration used in the
present experiments (1 mM) causes resting [Ca2+] to be low and
can effectively prevent SERCA-dependent SR Ca2+ uptake and
subsequent SR Ca2+ release, a major component of Ca2+-depen-
dent inactivation. However, this concentration of EGTA is well
below the one used in experiments in which Ca2+-dependent
inactivation of ICaL was explored. Intracellular dialysis with
much higher concentrations of this slow Ca2+ buffer (5–10 mM)
has been reported as poorly effective to buffer Ca2+ micro-
domains, allowing the detection of ICaL Ca2+-dependent inacti-
vation produced by Ca2+ entry through the channel and/or Ca2+
released through RYR2 (Masaki et al., 1997; Sham, 1997; You
et al., 1997). Indeed, studying the inactivation kinetics of the
current, we were able to detect faster ICaL inactivation in WT
myocytes exposed to high extracellular Ca2+ or in PLNKO than in
WT or S2814Dmyocytes exposed to 2.0 mM Ca2+ (Fig. S6). These
findings reflect a greater ICaL Ca2+-dependent inactivation in-
duced by the enhanced RYR2 release of Ca2+ in WT myocytes at
4.0 mM and in PLNKO myocytes.
A second possibility to explain the results of Fig. 3 may be
associated with the different SR Ca2+ contents that the four
mouse models have at the same extracellular Ca2+ concentration
(2.0 mM) at which τ values were obtained. As shown in Fig. 5 A,
SR Ca2+ content at 2.0 mM extracellular Ca2+ varies significantly
in the different mouse models: It was lower in S2814D than in
Figure 2. The increase in SR Ca2+ content
enhances CRR and Irel. (A) SR Ca2+ content
estimated by applying a caffeine pulse of 10 mM
in the absence of electrical stimulation. (B) SR
Ca2+ content obtained in the model at different
extracellular Ca2+ concentrations in WT my-
ocytes. (C) Typical CRR curves and overall re-
sults of τ values of CRR (inset) at 2.0 and
4.0 mM extracellular Ca2+. (D) Irel restitution
curves obtained in the model at different ex-
tracellular Ca2+ concentrations. The increase in
extracellular Ca2+ from 2.0 to 4.0 mM increased
SR Ca2+ content and decreased τ in WT my-
ocytes. Similar results were obtained in the
human myocyte model mimicking WT myocytes
when extracellular Ca2+ was increased from 1.5
to 2.5 mM. Experimental data are expressed as
mean ± SEM. Numbers inside bars represent
the number of animals used; numbers within
parentheses inside bars represent the number
of cells. When several cells per animal were
used, results of the number of cells in each
animal were averaged. The numbers used for
statistical analysis correspond to the number of
animals. P values are denoted above the bars.
Cely-Ortiz et al. Journal of General Physiology 5 of 13
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WT, reaching significant levels when compared by unpaired
Student’s t test, with a P value of 0.0125, and in SDKO versus
PLNKO myocytes, as expected by the enhanced RYR2 activity
(van Oort et al., 2010; Mazzocchi et al., 2016) and on the basis of
the present results (Fig. S7). Moreover, this parameter was
significantly higher in PLNKO than inWT and nearly significant
in SDKOmyocytes versus S2814Dmyocytes, reaching significant
levels when compared by unpaired Student’s t test (P = 0.0006),
as expected by ablation of PLN (Luo et al., 1994). Indeed, and in
agreement with previous findings (Mazzocchi et al., 2016), the
ablation of PLN (PLNKO and SDKO) significantly decreased τ
values of Ca2+ transient decay (Fig. 5 C). The myocyte model
shows results similar to those for the experimental data in mice
(Fig. 5, B and D). Taken together, these findings indicate that the
values of τ observed in the different mouse models may be af-
fected by the differences in SR Ca2+ contents. For instance, the
similar τ values of S2814D versus WT and of SDKO versus PLNKO
seen in Fig. 3, despite the lower SR Ca2+ content of S2814D and
SDKOwith respect toWT and PLNKO, respectively (Fig. 5), would
suggest that, for the same SR Ca2+ content, the increased activity of
RYR2 decreases τ. However, the role of RYR2 activity on τ, at a
given SR Ca2+ content, remains speculative on the basis of these
results. Moreover, it was not possible to differentiate between the
potential independent role of the speed of Ca2+ sequestration and
that of SR Ca2+ content itself on CRR (i.e., whether the enhance-
ment of CRR observed in PLNKO and SDKOmyocytes with respect
Figure 3. CRR is different in the different
mouse strains. (A) Typical raw data obtained in
WT, S2814D, PLNKO, and SDKO myocytes at
2.0 mM extracellular Ca2+. A1 and A2 indicate the
amplitude of the Ca2+ transient during regular
pacing and after the extra systolic stimulation,
respectively. The insets below show the pro-
gression of A2 values in the different strains.
(B and C) Typical experimental CRR curves ob-
tained in the four strains (B) and CRR curves in
the human myocyte model mimicking the mouse
strains (C) at the same extracellular Ca2+ con-
centration (2.0 mM). (D) Overall experimental
results of τ values of the four strains. (E) τ values
obtained in the human model mimicking the four
strains. τ was slightly but not significantly re-
duced in S2814D versus WT myocytes and sig-
nificantly reduced in PLNKO and SDKOmyocytes
with respect to both WT and S2814D myocytes.
The model reproduced the experimental data.
Experimental data are expressed as mean ±
SEM. Numbers inside bars represent the number
of animals used; numbers within parentheses in-
side bars represent the number of cells. When
several cells per animal were used, results of the
number of cells in each animal were averaged. The
numbers used for statistical analysis correspond to
the number of animals. P values are denoted above
the bars.
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to WT and S2814D, respectively, may be explained by either the
higher SR Ca2+ load or the increased rate of Ca2+ refilling typical of
these two mouse models).
Computational simulation predicts that CRR is determined by
SR Ca2+ load, Ca2+ sensitivity of RYR2, and velocity of SR
Ca2+ reuptake
In an attempt to unmask the already described effect of RYR2
activity on CRR (Ramay et al., 2011) and to dissect the possible
self-reliant role of the two tightly associated variables (i.e., the
rate of SR refilling versus SR Ca2+ content on CRR), we followed
a different strategy.We first interrogated the model by assessing
τ values ofWTsim and S2814Dsim humanmyocytes at different SR
Ca2+ concentrations obtained by increasing extracellular Ca2+.
With this approach, the influence of the increase in RYR2 ac-
tivity on τ could be explored at the same SR Ca2+ load. The points
follow two distinct curves: the S2814Dsim curve running ap-
proximately parallel to and below theWTsim curve (Fig. 6 A, gray
Figure 4. The different strains have similar
ICaL and ICaL restitution. (A) I-V relationship
was similar in WT, PLNKO, and S2814D my-
ocytes and was enhanced with increasing ex-
tracellular Ca2+. (B) Original traces of the
protocol used to assess ICaL restitution kinetics.
(C and D) Experimental and model results, re-
spectively, of ICaL restitution curves showing
that ICaL inactivation recovery is enhanced by
increasing extracellular Ca2+. (E and F) Experi-
mental and model results, respectively, of ICaL
restitution curves. Ablation of PLN or increased
RYR2 activity by RYR2 Ser2814 pseudophos-
phorylation did not significantly alter ICaL resti-
tution. Experimental data were expressed as
mean ± SEM. Numbers inside bars represent the
number of animals used; numbers within pa-
rentheses inside bars represent the number of
cells. When several cells per animal were used,
results of the number of cells in each animal
were averaged. The numbers used for statistical
analysis correspond to the number of animals. P
values are denoted above the bars.
Cely-Ortiz et al. Journal of General Physiology 7 of 13
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and magenta full circles). These results indicate that CRR is
faster in S2814Dsim myocytes than inWTsim myocytes for a given
SR Ca2+ load. We then plotted τ values of PLNKOsim and SDKOsim
myocytes and the corresponding SR Ca2+ contents obtained at
two different extracellular Ca2+ concentrations. We hypothe-
sized that if the rate of Ca2+ refilling plays a role in CRR different
from that of the SR Ca2+ load, the PLNKOsim and SDKOsim my-
ocyte data would fall below the WTsim and S2814Dsim curves,
respectively; that is, for a given SR Ca2+ load, τ would be lower.
Fig. 6 A indicates that this was not the case. PLNKOsim τ values
(green full circles) fell in the WTsim curve, whereas SDKOsim τ
points (light blue full circles) could be fitted to the S2814Dsim
curve. To compare whether the experimental results obtained in
mouse myocytes followed a pattern similar to that of the human
myocyte model, the obtained experimental and modeling results
of τ and SR Ca2+ load are represented in Fig. 6 B as the per-
centage of their respective WT values obtained at 2.0 mM ex-
tracellular Ca2+. As shown, the experimental values (crosses
representingmean ± SEM), followed a behavior similar to that of
the respective values of the model. PLNKO experimental data
(green cross) fell close to the WTsim curve, whereas S2814D and
SDKO experimental data (magenta and light blue crosses, re-
spectively) fell close to the S2814Dsim curve. Although at first
sight these results would indicate that the velocity of SR Ca2+
reuptake does not play a significant role in the determination of
CRR, a limitation of PLN ablated mice (PLNKO and SDKO) is that
RYR2 expression has been described to be reduced between 27%
(Chu et al., 1998) and 33% (Mazzocchi et al., 2016) with respect to
WT mice, as was confirmed in the experimental data shown in
Fig. S7 A.
As stated in the Materials and methods, the human myocyte
model mimicked this decrease. Decreasing the number of active
RYR2 sites led to a decrease in the Ca2+ released for a given SR
Ca2+ load (Zima et al., 2008), which would affect CRR. To avoid
the effects of RYR2 underexpression in mice with ablation of
PLN, we used the human myocyte model to calculate τ values in
PLNKOsim and SDKOsim at different SR Ca2+ concentrations
without introducing the change in RYR2 typical of these mice.
Fig. 6 B shows that the points corresponding to PLNKOsim and
SDKOsim without the correction for the decrease in RYR2
expression (i.e., noncompensated PLNKOsim and SDKOsim
[PLNKONC, green squares; SDKONC, light blue squares]) fell
below the corresponding WTsim and S2814Dsim curves. Thus,
by correcting in the model the decreased RYR2 expression
evoked by PLN ablation, these model curves move to the left. We
suggest that this might be an effect of the increase in SR Ca2+
reuptake and that the velocity of SR Ca2+ refilling might have
an effect on CRR that differs from that of SR Ca2+ load itself.
Although this could be a time-dependent manifestation of
[Ca2+] SR, further experimental studies are necessary to val-
idate this intriguing point.
Discussion
The beat-to-beat stability of CICR is essential to maintaining
normal cardiac function. Indeed, a large amount of experimental
evidence has associated the instability of cytosolic Ca2+ transient
amplitude with the propensity to cardiac alternans and the
risk for ventricular arrhythmias and sudden cardiac arrest
(Dı́az et al., 2002; Terentyev et al., 2002, 2003; Szentesi et al.,
2004; Wang et al., 2014; Kanaporis and Blatter, 2015; Sun
et al., 2018). The essential mechanism underlying beat-to-
beat stability is CRR. Several previous studies support the
notion that SR Ca2+ refilling as well as RYR2 activity are main
determinants of CRR at the subcellular and cellular levels
(Szentesi et al., 2004; Terentyev et al., 2008; Ramay et al.,
2011). However, some fundamental questions remain un-
answered, including the possible independent influence of the
velocity of Ca2+ refilling versus SR Ca2+ content on the re-
covery of Ca2+ release.
Figure 5. The different strains have different
SR Ca2+ loads at 2.0 mM extracellular Ca2+.
(A) SR Ca2+ load estimated by rapid caffeine
pulses at 2.0 mM extracellular Ca2+ in the dif-
ferent mouse strains. (B) SR Ca2+ loads obtained
in the human myocyte model, mimicking WT,
S2814D, PLNKO, and SDKO mouse myocytes. (C
and D) Experimental and model τ values of Ca2+
transient decay. Experimental data are ex-
pressed as mean ± SEM. Numbers inside bars
represent the number of animals used; numbers
within parentheses inside bars represent the
number of cells. When several cells per animal
were used, results of the number of cells in each
animal were averaged. The numbers used for
statistical analysis correspond to the number of
animals. P values are denoted above the bars.
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In the present study, we employed a knock-in mouse model
harboring a mutation of RYR2 at the Ser2814 site (S2814D) to
enhance the activity of RYR2 (Wehrens et al., 2004; van Oort
et al., 2010; Mazzocchi et al., 2016), the PLNKO mouse model, to
enhance SR Ca2+ reuptake and refilling (Luo et al., 1994), and the
SDKO mouse model (Mazzocchi et al., 2016; Valverde et al.,
2019). To better define the relative roles of the different play-
ers known to determine CRR as well as to dissect the relative
importance of the velocity of SR Ca2+ refilling versus SR Ca2+
load on CRR, we used a previously validated mathematical hu-
man myocyte model (Lascano et al., 2013; Mazzocchi et al.,
2016). The present results show the following: (1) The increase
in SR Ca2+ content produced by increasing extracellular Ca2+
enhances CRR; (2) the increase in RYR2 activity produced by
constitutive pseudophosphorylation of RYR2 at the Ser2814 site
increases the velocity of CRRwith respect toWTmyocytes when
compared at the same SR Ca2+ content in a wide range of SR Ca2+
contents; and (3) the enhanced velocity of SR Ca2+ refilling ac-
celerates CRR independently of the associated increase in SR
Ca2+ load.
CRR is enhanced by increasing SR Ca2+ content
To investigate the role of SR Ca2+ content in CRR, we increased
SR Ca2+ content by increasing extracellular Ca2+. We concluded
on the basis of these experiments that the increase in SR Ca2+
content decreases τ; that is, it enhances CRR. However, the
strategy used to increase SR Ca2+ load entails the difficulty that
the increase in extracellular Ca2+ may affect cytosolic Ca2+. Ex-
perimental evidence obtained in past decades suggests that Ca2+
refractoriness is probably mediated by mechanisms that reside
in the luminal side of the SR (Jiang et al., 2004; Sobie and
Lederer, 2012). However, RYR2 opening rate may also be
influenced by changes in local diastolic Ca2+, either directly or
through the activation of calmodulin (CaM), known to inhibit
RYR2 and ICaL (Søndergaard et al., 2015; Vassilakopoulou et al.,
2015), or by the enhancement of CaMKII activity, known to
produce the opposite effects (Yuan and Bers, 1994; van Oort
et al., 2010). The present results indicated that diastolic Ca2+
did not change significantly when increasing extracellular Ca2+,
which makes improbable any influence of cytosolic Ca2+ on the
enhancement of CRR observed when SR Ca2+ was under this
condition. However, we are aware of the fact that a moderate
increase in diastolic Ca2+ might not have been detected by the
fluorescence method used to measure intracellular Ca2+. More-
over, and possibly more important, the increase in SR Ca2+ re-
lease produced by increasing extracellular Ca2+ or that observed
in PLNKO and SDKO myocytes with respect to WT or the en-
hanced SR Ca2+ leak of S2814D may locally enhance cytosolic
Ca2+ and, by activating CaM, inhibit RYR2 (Xu and Meissner,
2004) and slow CRR (Sun et al., 2018). If this were the case, our
results would have underestimated the increase in CRR velocity
produced when extracellular Ca2+ was increased or that ob-
served in PLNKO, SDKO, and S2814D with respect to WT my-
ocytes. However, the effect of cytosolic Ca2+ on CRR is not
completely clear, and possible additional actors may be playing a
role. For instance, an increase in diastolic Ca2+ may also stimu-
late CaMKII and phosphorylate RYR2 (Wehrens et al., 2004),
which would help to accelerate CRR and would tend to coun-
teract the activation of CaM, except in S2814D and SDKO
myocytes, in which the RYR2 CaMKII site cannot be phos-
phorylated. In these latter cases, the sole influence of CaM ac-
tivation would again underestimate the increase in the CRR
observed. Thus, the present results cannot discard a possible
Figure 6. CRR is enhanced by the increase in SR Ca2+ content, the
CaMKII-dependent increased activity of RYR2, and the velocity of SR
Ca2+ reuptake. (A)Mathematical model curves showing τ as a function of SR
Ca2+ load in human myocytes mimicking WT (gray) and S2814D (magenta)
myocytes. τ decreases with increasing SR Ca2+ load in both WTsim and
S2814Dsim following two different exponential curves which indicate that, for
a given SR Ca2+ load, τ is lower in S2814Dsim. The green and light blue full
circles indicate the relationship between τ and SR Ca2+ load in PLNKOsim and
SDKOsim myocytes. The points fell in the WTsim and S2814Dsim curves, re-
spectively. (B) The same curves of A are represented as percentage τ values
and SR Ca2+ loads obtained in WTsim myocytes at 2.0 mM extracellular Ca2+
to allow comparison with the experimental CRR data, similarly expressed as
percentage values. As shown, the experimental points (crosses) of WT and
PLNKO myocytes fell in the WTsim curve, whereas the experimental points of
S2814D and SDKO myocytes fell in the S2814Dsim curve. Green and light blue
squares represent τ values at different SR Ca2+ loads in PLNKOsim and
SDKOsim human myocytes without the compensatory decrease (non-
compensated, NC) in the expression of RYR2 produced by PLN ablation
(PLNKONC and SDKONC). As shown, the points follow a curve (dashed line)
that is below the respective WTsim and S2814Dsim curves, indicating that for
the same SR Ca2+ load, the increase in the velocity of Ca2+ refilling decreases
τ (enhances Irel restitution) independently of the effect of SR Ca2+ content on
CRR. Experimental data are expressed as mean ± SEM.
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influence of putative changes in cytosolic Ca2+ on the values of
CRR observed, although the above reasoning would suggest that
this influence, if any, would underestimate the observed ac-
celeration of CRR under the different conditions.
Increasing RYR2 activity by constitutive
pseudophosphorylation of RYR2 enhances CRR
Previous experiments have shown that β-adrenoceptor stimu-
lation enhances CRR (Szentesi et al., 2004; Ramay et al., 2011;
Poláková et al., 2015). Although Ramay et al. (2011) concluded
that β-adrenoceptor stimulation increases CRR by enhancing SR
Ca2+ reuptake through PLN phosphorylation and increasing
RYR2 sensitivity, possibly through PKA or CaMKII phospho-
rylation, Poláková et al. (2015) further indicated that maximal
RYR2 activation by PKA and CaMKII phosphorylation was re-
quired to enhance CRR. Our experiments describe, for the first
time, that the increase in RYR2 sensitivity evoked by constitu-
tive pseudophosphorylation of RYR2 at the CaMKII site is suf-
ficient to increase CRR at a given SR Ca2+ load. The reason for
this apparent discrepancy with Poláková’s results is not cur-
rently clear. A potential explanation is that the level of RYR2
sensitization produced by the independent isoproterenol-induced
phosphorylation of each site (Ser2814 or Ser2808) may be
lower than that evoked by constitutive pseudophosphorylation
of Ser2814 (S2814D mice) and therefore not sufficiently high
to accelerate CRR.
Increasing the velocity of SR Ca2+ refilling enhances CRR
Szentesi et al. (2004) were the first to describe that increasing
SR Ca2+ refilling enhances CRR. The idea of SR Ca2+ refilling
encompasses the concept of velocity. Indeed, the authors used
PLNKO mice to support their pharmacological findings obtained
when the variation of SR Ca2+ refilling was produced by the
combined use of β-adrenoceptor stimulation and drugs that
decrease SERCA2a activity (e.g., thapsigargin). However, these
experiments failed to differentiate the effect on CRR of SR Ca2+
content, necessarily increased by increasing SR Ca2+ sequestra-
tion, and the velocity of SR Ca2+ refilling.Moreover, the decrease
in RYR2 expression presented by PLNKO mice (Chu et al., 1998;
Mazzocchi et al., 2016) also precludes a precise analysis of the
velocity of SR Ca2+ reuptake on CRR. Indeed, the results obtained
with the human myocyte model that mimicked PLNKO my-
ocytes indicated that the velocity of SR Ca2+ refilling did not
influence CRR: The τ value obtained for the PLNKOsim myocyte
was similar to that of WT over the same corresponding SR Ca2+
loads. To avoid these complications and to dissect the possible
independent effects of SR Ca2+ content and the velocity of SR
Ca2+ refilling on CRR, we used a mathematical model able to
represent the behavior of a “pure” PLNKO myocyte without
compensatory mechanisms on RYR2 (PLNKONC). For this pur-
pose, the activity of SERCA2a was increased by 50%, whereas the
expression of RYR2 was left at the normal (WT) level. Similarly,
for PLNKONC, the “pure” SDKOmyocytemodel was built without
the correction of RYR2 due to PLN ablation while preserving the
increased RYR2 activity of S2814D (SDKONC). The results clearly
indicated that the increase in the velocity of refilling increases
CRR independently of the action of SR Ca2+ content on CRR.
Relative importance of different factors that influence CRR
Previous results using direct [Ca]SR measurements showed that
even after complete recovery of SR Ca2+ content, RYR2 refrac-
toriness was still present (Picht et al., 2006; Belevych et al.,
2012). According to these findings, the rate-limiting factor for
CRR appears to be the recovery of RYR2 activity. At first sight,
the importance of the rate of SR Ca2+ refilling on CRR suggested
by the present findings seems to be at odds with these previous
results (Picht et al., 2006; Belevych et al., 2012). However, it is
important to emphasize that our results cannot establish the
relative importance of the different determinants of CRR. Our
goal was to dissect different variables that are difficult to sepa-
rate experimentally because of being tightly intertwined and
that may play a role in CRR. In this sense, the use of mutant mice
in combinationwithmathematical modeling proved to be useful.
Confirming the previous findings, the results demonstrated that
RYR2 refractoriness and SR Ca2+ content both play a role in CRR.
Mathematical modeling further suggests that the velocity of SR
Ca2+ refilling is also involved. Despite the extensive evidence
indicating the importance of luminal Ca2+ on RYR2 gating reg-
ulation and RYR2 refractoriness, the specific molecular mecha-
nisms of CRR regulation by luminal Ca2+ are not completely
clarified. RYR2 regulation by intraluminal Ca2+ may occur di-
rectly (Jiang et al., 2004, 2007) or indirectly through the in-
volvement of different intraluminal SR proteins, such as CASq2,
triadin, and junctin, acting in concert (Zhang et al., 1997; Györke
et al., 2004; Knollmann et al., 2006; Chopra et al., 2009), or
histidine-rich Ca2+-binding protein (Arvanitis et al., 2011). In-
creasing SR Ca2+ refilling rate may therefore act by accelerating
the achievement of the necessary luminal Ca2+ level to trigger
RYR2 opening and/or by increasing the coupling of Ca2+ release
units inside the SR (Qu et al., 2013). Indeed, an intriguing finding
of the experiments by Belevych et al. (2012) is that the lower SR
Ca2+ load presented by postinfarction myocytes (associated with
an increase of the RYR2 activity) was attained before RYR2 re-
covery from refractoriness. This finding would suggest a partial
recovery of RYR2 unable to evoke spontaneous events but re-
sponsible for maintaining the low SR Ca2+ content exhibited by
these myocytes. If this were the case, an increase in the velocity
of SR Ca2+ refilling would contribute to favor at least this partial
restitution. A second possibility would be that the recovery of
RYR2 from refractoriness can proceed only after a given level of
SR Ca2+ content is reached. In this case, the velocity of SR Ca2+
recovery may play an important role in CRR. Further experi-
ments are needed to clarify this intriguing point.
In summary, our experiments confirmed that CRR is deter-
mined by SR Ca2+ load and RYR2 Ca2+ sensitivity. We further
raise the possibility that the velocity of SR Ca2+ refilling may be
an important player in controlling CRR, independent of SR Ca2+
content.
Limitations of the study
There are a number of caveats to consider in the present results.
Previous studies revealed an expansion of SR volume and
downregulation of triadin 1 and junctin in myocytes from
Casq2−/− mice, in which SR Ca2+ release refractoriness was al-
most completely absent (Kryshtal et al., 2015). These SR changes
Cely-Ortiz et al. Journal of General Physiology 10 of 13
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were interpreted as a compensatory mechanism for the loss of
SR Ca2+ buffering by Casq2, the major intra-SR Ca2+ buffering
protein (Bers, 2001). As far as we understand, and in contrast to
what happens with Casq2−/−mice, there are no apparent reasons
to expect a change in the buffer capacity and/or the SR volume
in the mouse models used in the present experiments. Indeed,
previous experiments in PLNKO showed no apparent changes in
the junctional and free SR ultrastructure, organization, and
distribution in PLNKO myocytes (Chu et al., 1998). We also
considered the possibility that a small change in Casq2 expres-
sion in our models could have produced a change in SR volume
and buffer capacity, because the 50% increase in SR volume in
Casq2−/− mice almost fully compensated for the lack of Casq2
buffering (Bers, 2001). Again, previous experiments indicated
that Casq2 expression did not change in PLNKO myocytes (Chu
et al., 1998) or in right atrial samples from patients with chronic
atrial fibrillation that presented an increase in Ser2814 and
Ser2808 phosphorylation of RYR2 (Voigt et al., 2012), which
may have produced adaptive changes similar to those that oc-
curred in S2814D myocytes. The present results confirmed that
Casq2 expression did not change in any of the mouse strains
studied (Fig. S7 B). Thus, althoughwe cannot completely rule out
the possibility of changes in SR volume or buffer capacity in our
experiments that could have affected our conclusions, this
possibility seems unlikely.
We are also aware that another limitation of our study is the
difficulty in showing experimentally the importance of the ve-
locity of SR Ca2+ refilling as a factor determining CRR inde-
pendently of SR Ca2+ load because of the tight association
between these two parameters. The fact that the τ of [Ca2+]i
decline is similar to the CRR τ for all cases, in which the former
is an indirect [Ca2+]SR refilling level (Figs. 5 and 3, respectively),
supports the critical importance of SR Ca2+ content for CRR.
Unfortunately, the present experiments cannot distinguish the
velocity of SR Ca2+ refilling at themoment of release from the level
of [Ca2+]SR at that time. However, one advantage of using math-
ematical models is that they give access to variables that are hard
to measure experimentally or that are tightly intertwined. In the
present study, themathematical model proved to reproduce all the
experimental data. This strength gives us great confidence in the
results predicted by the model. Moreover, the fact that the ex-
perimental values of τ of PLNKO and SDKO fall on the curve
generated by the model for WT and S2814D, in spite of having a
30% decrease in RYR2 expression (Fig. S7 A), is experimentally in
line with the contention that the increase in the velocity of re-
filling is a determinant of CRR. Future voltage-clamp experiments
with real-time [Ca2+]SR measurements are needed to experimen-
tally support the independent role of the velocity of SR Ca2+ re-
filling in CRR suggested by the mathematical model.
Another limitation of our results is that the experiments
performed to study recovery of ICaL and CRR were not carried
out in the same cell. Moreover, the 50-ms square pulse to 0 mV
used to measure ICaL is different from the Vm waveform that
drives Ca2+ current in the pacedmyocytes. Although comparison
of ICaL recovery with CRR in the same cell would have been a
better approach, the results clearly showed that the recovery of
the ICaL did not change in the different strains. Therefore, it
cannot be responsible for the changes in CRR observed. More-
over, the square pulse protocol is a widely validated protocol
reported in the literature to determine ICaL restitution (Tseng,
1988; Vornanen and Shepherd, 1997; Guo and Duff, 2006;
Kryshtal et al., 2015).
We used the Negroni-Lascano human myocyte model
(Mazzocchi et al., 2016), modified to improve the Ca2+ handling
properties of the ten Tusscher model (ten Tusscher et al., 2004)
by including the Shannon-Bers RYR2 four-state model (Shannon
et al., 2004). Therefore, an additional limitation of our study is
that we did not use a mathematical mouse myocyte model.
However, because the model reproduces experimental results
obtained not only in mouse myocytes (Mazzocchi et al., 2016,
and the present results) but also in rat, sheep, and canine my-
ocyte experiments performed in other laboratories (Trafford
et al., 2000; Greensmith et al., 2014), we can still consider it
as a valid tool to interpret our results.
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Supplemental material
Measurements of [3H]ryanodine binding in mouse ventricular homogenates
Preparation of tissue homogenates
Freshly dissected hearts were drained free of blood in Tyrode solution. The left ventricle was suspended in cold lysis buffer con-
taining phosphatase and protease inhibitors (2 µM leupeptin, 100 µM PMSF, 500 µM benzamidine, 100 nM aprotinin, and 20 mM
NaF) and homogenized using a Teflon pestle. The homogenized tissue was centrifuged at 1,000 g for 10 min at 4°C. Supernatants
were aliquoted and stored at −80°C until used. The protein concentration was determined by the Bradford method.
[3H]ryanodine binding assays
Binding assays were carried out following a modified version of a protocol previously described (Helms et al., 2016). Binding
mixtures were prepared containing 75–100 µg of protein from the tissue homogenate, 0.2 M KCl, 40 mM Na-HEPES (pH 7.4), 5 nM
[3H]ryanodine (PerkinElmer), 1 mMEGTA, and enough CaCl2 to set free [Ca2+] in the range of 10 nM to 100 μM. The Ca2+/EGTA ratio
for these solutions was determined using MAXCHELATOR (https://somapp.ucdmc.ucdavis.edu/pharmacology/bers/maxchelator/).
The binding reactions were incubated for 2 h at 37°C, then filtered through Whatman GF/B filters in an M24-R Harvester (Brandel).
Nonspecific binding was determined in the presence of 20 µM ryanodine (MP Biomedicals). [3H]ryanodine binding was measured
by liquid scintillation.
Western blotting
Stored mouse ventricles were homogenized in 4 vol of lysis buffer (in mM): 20 sodium glycerolphosphate, 20 NaF, 1 EGTA, 2 EDTA,
0.2 Na2VO4, 2 dithiothreitol, 10 benzamide, 1 PMSF, 0.001 pepstatin, 1% IGEPAL, 0.01% Triton X-100, and 0.048 mg/ml leupeptin.
Protein was measured by the Bradford method using BSA as a standard. Lysates (~90 μg of total protein) were separated per gel line
in 10% SDS polyacrylamide gel (Mundiña-Weilenmann et al., 1996) and transferred to polyvinylidene difluoride membranes (Im-
mobilon; MilliporeSigma). Blots were probed overnight with specific primarymAb at 4°C: RYR2 (1:1,000; Badrilla) and calsequestrin
2 (1:1,000; Invitrogen). The blots were then washed and incubated with secondary antibody (goat anti-rabbit and goat anti-mouse;
Santa Cruz Biotechnology) for 2 h at room temperature. Immunoreactivity was visualized using a peroxidase-based chemilumi-
nescence detection kit (Amersham Biosciences) with the ChemiDoc imaging system. The signal intensity of the bands in the im-
munoblots was quantified by densitometry using ImageJ software (National Institutes of Health).
Confocal imaging of intact cardiac myocytes
Freshly isolated mouse ventricular myocytes were loaded with 10 μM Fluo 3-AM (Molecular Probes) in Tyrode buffer containing
2.5 mM Ca2+ for 20 min at room temperature and mounted in a small chamber placed onto an inverted microscope equipped with a
63× lens objective as previously described (Palomeque et al., 2009). After stabilization (usually 3–5 min), confocal line scanning (512 ×
512 pixels and 4.3 ms per line) was performed along the longitudinal axis of cells (avoiding nuclei) using the Zeiss LSM 410 confocal
system in quiescent cells. The Fluo 3-AM–loaded myocytes were excited using the 488-nm argon laser, and the fluorescence emission
was recorded at 500–550 nm. This procedurewas repeated under high extracellular Ca2+ (6.0mMCa2+) to induce SR Ca2+ overload. Cells
were paced at 0.5 Hz for 30 s, and then pacing was stopped to register Ca2+ sparks. Ca2+ sparks were visually counted and expressed as
the number of events per second, normalized to 100 μm (spark frequency).
Modeling
The modified ten Tusscher-Panfilov model (ten Tusscher et al., 2004) essentially consists of four Ca2+ compartments: cytosol, two
dyadic clefts, and SR. Upon activation and L-type Ca2+ channel opening, Ca2+ is released from the SR by the CICRmechanism. This is
described as Ca2+ release from the SR to the first cleft (DC1) through the RYR2 facing the L-type Ca2+ channels, and this Ca2+ then
diffuses to the second cleft (DC2), inducing further CICR from the RYR2 not facing the L-type Ca2+ channel. Then, all the Ca2+ in DC2
either diffusing from DC1 or directly released to DC2 passes to cytosol, giving rise to the Ca2+ transient. Ca2+ release into DC1 and DC2
was based on the four-state Shannon model (Shannon et al., 2004) with open (O), rest (R), inhibited (I), and partially inhibited (IR)
states, where the rate constants between them are governed by [Ca2+] in the SR and Ca2+ release is given by:
Irelease  Vrel.O. Ca2+[ ]SR( ) − Ca2+[ ]DC( ){ },
where DC is DC1 or DC2 as appropriate. In addition, SR Ca2+ leak was represented as Ca2+ flow through the RYR2modulated by the R
state of this channel as follows:
Ileak  Vsp.R. Ca2+[ ]SR( ) − Ca2+[ ]DC( ){ },
Cely-Ortiz et al. Journal of General Physiology S1
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resulting in total Ca2+ release through the RYR2 as follows:
Irel  Irelease + Ileak
(Lascano et al., 2013). Othermodel equations and parameter values were adopted from ten Tusscher and Panfilov (ten Tusscher et al.,
2004; ten Tusscher and Panfilov, 2006).
Figure S1. Schematic diagram of the model. Human myocyte model including ion pumps and exchangers responsible for action potential, Ca2+ manage-
ment, force development, pHi, and CaMKII regulation. Our previous model (Lascano et al., 2013) was modified by the addition of a second dyadic cleft: DC1 and
DC2. The model is coupled to the myofilament force development model consisting of five-state troponin systems (TSs) with Ca2+ binding at the myofilament
level (Negroni et al., 2015). AE, anion exchanger; Cap, membrane Ca2+-ATPase; CHE, Cl−/OH− exchanger; CYTO, cytosol; LTCC, L-type Ca2+ channels; NBC,
Na+–HCO3− cotransporter; NCX, Na+/Ca2+ exchanger; NHE, Na+/H+ exchanger; NKA, Na+/K+-ATPase.
Figure S2. Ca2+ transients or Irel restitution curves have a similar behavior in the human myocyte model. (A and B) Cytosolic Ca2+ ([Ca2+]i) transient
restitution (blue dots) and Irel restitution (red dots) have similar behaviors in the human myocyte model as shown for WT myocytes (A) and S2814D myocytes
(B).
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Figure S3. S2814Dmice show increased [3H]ryanodine binding and SR Ca2+ sparks frequency. (A and B) Pseudophosphorylation of RYR2 at Ser2814 site
(S2814D) significantly increases maximal density of high-affinity [3H]ryanodine binding sites (A) and the frequency of SR Ca2+ sparks (B). Data are expressed as
mean ± SEM. n, number of animals. In B, numbers within parentheses are the number of cells.
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Figure S4. Raw data of the experimental protocol used to determine CRR curves. (A–D) Raw data of cytosolic Ca2+ measurements for WT (A), S2814D
(B), PLNKO (C), and SDKO (D) myocytes used for CRR curves construction.
Figure S5. ICaL restitution ofWT, PLNKO, and S2814D recorded at 0mV from a holding potential of −60mV.No changes were observed in the different
strains. Right: Representative traces of the current evoked by the restitution protocol with the holding potential at −60 mV. The currents in the absence and
presence of nifedipine and the nifedipine-sensitive current (difference current) are shown. The difference current was obtained by subtracting the current in
the presence of nifedipine from the current recorded in its absence. Left: Average ICaL restitution determined in WT, PLNKO, and S2814D myocytes. The ICaL
restitution time constants are shown in the inset. Data are expressed as mean ± SEM.
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Figure S6. The increase in extracellular Ca2+ and the ablation of PLN enhance ICaL inactivation kinetics. Right: Representative traces of the current
evoked by the first pulse to 0 mV of the restitution protocol recorded in myocytes of WT at 2 mM and 4 mM extracellular Ca2+ of PLNKO and of S2814D. Left:
Average values of the time constants of inactivation of ICaL. Time constants were obtained after fitting the current traces from peak current to the end of the
pulse with a monoexponential decay equation: f(t)  Pni1Aie−t/τi + C. Data are expressed as mean ± SEM.
Figure S7. Typical Western blots and overall results of RYR2 expression. (A) Results confirm the previously described decrease of ∼30% in RYR2 ex-
pression in PLNKO and SDKO mice with respect to WT mice (Chu et al., 1998; Mazzocchi et al., 2016). Each bar represents mean data of six WT and SDKO
hearts and three PLNKO hearts. (B) Casq2 expression does not significantly change in S2814D, PLNKO, and SDKO with respect to WT mouse hearts. Each bar
represents mean data of five WT, S2814D, and SDKO hearts and four PLNKO hearts. Data are expressed as mean ± SEM.
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